Title : [Sunitinib: 10 years after approval for the therapy of metastatic renal cell carcinoma].

Pub. Date : 2016

PMID : 30695560






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sunitinib is one of first targeted agents and tyrosine kinase inhibitors of vascular endothelial growth factor receptor (VEGFR) that approved for therapy of metastatic renal cell carcinoma. Sunitinib kinase insert domain receptor Homo sapiens
2 Sunitinib is one of first targeted agents and tyrosine kinase inhibitors of vascular endothelial growth factor receptor (VEGFR) that approved for therapy of metastatic renal cell carcinoma. Sunitinib kinase insert domain receptor Homo sapiens